PAVmed, Inc. Ownership
$3.82
0.65%
Nasdaq, Sep 28, 02:16 pm EDT.
Market open.
Index
Industry
PAVmed, Inc. Top Shareholders
| # | Holder | Shares | % of Shares Out | Change | Filing Date |
|---|---|---|---|---|---|
| 1 |
Tasso Partners, LLC
|
912.996k | 14.56% | +827.184k | Mar 27 2026 |
| 2 |
Scopia Capital Management LP
|
630.118k | 10.05% | +630.118k | Mar 27 2026 |
| 3 |
Nagelberg (David S)
|
546.964k | 8.72% | +546.964k | Mar 27 2026 |
| 4 |
Kallman (Craig)
|
384.616k | 6.13% | +384.616k | Mar 27 2026 |
| 5 |
Aklog (Lishan)
|
367.573k | 5.86% | +359.949k | Apr 02 2026 |
|
1
Tasso Partners, LLC
|
14.56%
912.996k
|
|
2
Scopia Capital Management LP
|
10.05%
630.118k
|
|
3
Nagelberg (David S)
|
8.72%
546.964k
|
|
4
Kallman (Craig)
|
6.13%
384.616k
|
|
5
Aklog (Lishan)
|
5.86%
367.573k
|
| The largest shareholders show who really holds influence: big institutional owners shape a stock's liquidity, and building or cutting positions can move the price. | |
| The 5 largest shareholders together hold 45.33% of PAVmed, Inc., with Tasso Partners, LLC the biggest at 14.56%, followed by Scopia Capital Management LP (10.05%) and Nagelberg (David S) (8.72%). |
PAVmed, Inc. Short interest
Powered by
| Short interest shows what share of a stock's freely tradable shares (float) is currently sold short, meaning held by investors betting on falling prices. A high or rising level can be read two ways: it reflects the skepticism of many market participants, but also carries upside potential. Because if the stock rises, short sellers have to buy back, which can push the price up even further. This effect is called a short squeeze. | |
| The short interest in PAVmed, Inc. has fallen over the past 12 months from around 2.3% to 0.2% of the float. Fewer and fewer market participants are betting on falling prices. That points to easing skepticism, as short sellers increasingly unwind their positions. |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
